Founders Fund portfolio Biotech companies
Contrarian venture firm investing in deeptech, defence, and breakthrough software. Filtered to companies in Biotech.
Edit the query above, or pick a refinement. 500 free credits on sign-up, no card needed.
- InvestorFounders Fund
- IndustryBiotech
- Matches33
Built from a search like: “Founders Fund-backed Biotech companies”
Ranked by current headcount across Founders Fund-backed Biotech companies. Refreshed daily.
- 1Natera· Austin, Texas, United States
NateraTM is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. Please be advised that Natera will only reach out to candidates with an @natera.com email domain. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.https://www.natera.com/privacy/
- Post-IPO equity
- 5.9k employees
- Founded 2004
- 2Neuralink· Austin, Texas, United States
Neuralink is a neurotechnology company building a generalized input/output platform for the brain. Our work has the potential to restore autonomy to those with unmet medical needs and fundamentally transform how humans interact with the world.Our core technology is an implantable brain-computer interface with ultra-thin, flexible electrode threads placed precisely by a surgical robot, enabling high-bandwidth, bidirectional interaction with neural signals.We’ve received multiple FDA Breakthrough Device designations and are conducting clinical trials around the world. Trial participants are exploring how our implant could enhance their daily lives — controlling digital devices like computers and smartphones, operating physical devices like robotic arms and wheelchairs, and translating thought directly into speech and text.Developing brain-computer interfaces is an interdisciplinary challenge, and we’re looking for exceptional talent across engineering, science, and operations. Explore opportunities to contribute to our mission at neuralink.com/careers.
- Series unknown
- 708 employees
- Founded 2016
- 3Freenome· Brisbane, California, United States
Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
- Post-IPO equity
- 408 employees
- Founded 2014
- Live search
This list is a starting point
I can run a natural-language search across LinkedIn, GitHub, and the open web. Fire one of these, or edit the box up top to match exactly who you're after.
500 free credits on sign-up, no card needed.
- 4Ultima Genomics· Fremont, California, United States
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.
- Series unknown
- 309 employees
- Founded 2016
- 5Roivant· New York, New York, United States
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
- Post-IPO equity
- 229 employees
- Founded 2014
Founders Fund’s Biotech portfolio
The list above ranks Founders Fund-backed Biotech companies by current headcount, drawn from public LinkedIn and Crunchbase records. 33 matching companies in Refolk’s index give you a quick read on where Founders Fund has gone deepest in the Biotech space.
Founders Fund’s Biotech bets tend to share a thesis. The engineers, ML researchers, and founders inside these companies are often building the same primitives - and they show up in Biotech talent pools across the next decade.
Refolk converts this list into a live search. Ask for “Founders Fund Biotech companies hiring senior engineers” or “founders of Founders Fund-backed Biotech companies” and Refolk returns a fresh ranked shortlist.
How this list is built
Last refreshed: Wed, 05 Aug 2026 11:08:53 GMT
Need a more specific search?
Refolk runs natural-language searches across LinkedIn, GitHub, and the open web. Try one of these:
Related lists
- Founders Fund · AI
- Andreessen Horowitz · Biotech
- GV (Google Ventures) · Biotech
- Y Combinator · SaaS
- Y Combinator · Fintech
- Y Combinator · AI
- Y Combinator · Developer tools
- Andreessen Horowitz · AI
See all company lists.
Or zoom out
Common questions
How is this ranking built?
The list draws on the public company graph - headcount and growth signals, funding history, and recency. The criteria chips at the top show exactly which filters produced it, and the methodology section explains the ranking.
How fresh is the data?
The underlying index updates continuously and this page re-renders at least daily. Last refreshed: Wed, 05 Aug 2026 11:08:53 GMT.
Can I get the full list of 33 companies?
Yes. This page shows the top of the ranking; sign up and I'll run the search live for the complete, current list. You start with 500 free credits, no card required.
Can I find the people inside these companies?
Yes. Ask in plain English - for example "engineering leaders at these companies who joined in the last year" - and I return the specific people, with context on each.